Back to Search
Start Over
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.
- Source :
-
European journal of immunology [Eur J Immunol] 2022 Jul; Vol. 52 (7), pp. 1194-1197. Date of Electronic Publication: 2022 Apr 28. - Publication Year :
- 2022
-
Abstract
- Little is known about the cellular immune response to SARS-CoV-2 vaccination in patients after HSCT and B-NHL with iatrogenic B-cell aplasia. In nonseroconverted HSCT patients, induction of specific T-cell responses was assessed. The majority of allogeneic HSCT patients not showing humoral responses to vaccination also fail to mount antigen-specific T-cell responses.<br /> (© 2022 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.)
Details
- Language :
- English
- ISSN :
- 1521-4141
- Volume :
- 52
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- European journal of immunology
- Publication Type :
- Academic Journal
- Accession number :
- 35389515
- Full Text :
- https://doi.org/10.1002/eji.202149771